{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:30:08Z","timestamp":1775097008958,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Basic Research Program of China","award":["2014CB942903"],"award-info":[{"award-number":["2014CB942903"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370978"],"award-info":[{"award-number":["81370978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frontier Technology Joint Research Program","award":["12013115"],"award-info":[{"award-number":["12013115"]}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTC2013jcyjC00009"],"award-info":[{"award-number":["CSTC2013jcyjC00009"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["14JC1405000"],"award-info":[{"award-number":["14JC1405000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bone.2016.09.017","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T19:49:46Z","timestamp":1474487386000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors"],"prefix":"10.1016","volume":"93","author":[{"given":"Zhe","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-zhen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7093-4584","authenticated-orcid":false,"given":"Zhen-lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2016.09.017_bb0005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.09.017_bb0010","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.09.017_bb0015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1523-1755.2004.00866.x","article-title":"Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies","volume":"66","author":"Izzedine","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.09.017_bb0020","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/00002030-200109070-00013","article-title":"The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial","volume":"15","author":"Fisher","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2016.09.017_bb0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1210\/jc.2009-2051","article-title":"Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B","volume":"95","author":"Wong","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.09.017_bb0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00774-012-0384-y","article-title":"Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review","volume":"31","author":"Kim du","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2016.09.017_bb0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.11005\/jbm.2014.21.1.76","article-title":"Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review","volume":"21","author":"Jeong","year":"2014","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.bone.2016.09.017_bb0040","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1097\/MJT.0b013e31820c4b20","article-title":"Acquired Fanconi syndrome associated with prolonged adefovir dipivoxil therapy in a chronic hepatitis B patient","volume":"20","author":"Law","year":"2013","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.bone.2016.09.017_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10157-012-0762-8","article-title":"Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-dose adefovir dipivoxil","volume":"17","author":"Shimohata","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.bone.2016.09.017_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/jcpt.12050","article-title":"Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition","volume":"38","author":"Wu","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bone.2016.09.017_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/NCN-100002341","article-title":"Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs","volume":"20","author":"Cihlar","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.bone.2016.09.017_bb0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nephro.2005.06.011","article-title":"Tubular transporters OAT1 and MRP2 and clearance of adefovir","volume":"1","author":"Servais","year":"2005","journal-title":"Nephrol. Ther."},{"key":"10.1016\/j.bone.2016.09.017_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2006.04.047","article-title":"Tubular transporters and clearance of adefovir","volume":"540","author":"Servais","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bone.2016.09.017_bb0070","first-page":"567","article-title":"Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule","volume":"299","author":"Miller","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bone.2016.09.017_bb0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2016.09.017_bb9000","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods."},{"key":"10.1016\/j.bone.2016.09.017_bb9100","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bone.2016.09.017_bb9200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods."},{"key":"10.1016\/j.bone.2016.09.017_bb0080","doi-asserted-by":"crossref","first-page":"513925","DOI":"10.1155\/2013\/513925","article-title":"Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women","volume":"2013","author":"Hu","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bone.2016.09.017_bb0085","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/00002030-200404090-00019","article-title":"Tenofovir-related nephrotoxicity in HIV-infected patients","volume":"18","author":"Barrios","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2016.09.017_bb0090","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bone.2016.09.017_bb0095","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(05)62506-8","article-title":"Urinary stones in HIV-1-positive patients treated with indinavir","volume":"349","author":"Daudon","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2016.09.017_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJM199701093360215","article-title":"Indinavir nephropathy","volume":"336","author":"Tashima","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.09.017_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0272-6386(96)90369-8","article-title":"Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy","volume":"27","author":"Navarro","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2016.09.017_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3851\/IMP2954","article-title":"Low-dose adefovir dipivoxil may induce Fanconi syndrome: clinical characteristics and long-term follow-up for Chinese patients","volume":"20","author":"Xu","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bone.2016.09.017_bb0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jcpt.12259","article-title":"Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil","volume":"40","author":"Wang","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bone.2016.09.017_bb0120","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bone.2016.09.017_bb0125","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","article-title":"NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity","volume":"112","author":"Wojnowski","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2016.09.017_bb0130","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/508546","article-title":"Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy","volume":"194","author":"Izzedine","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bone.2016.09.017_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.clpt.6100269","article-title":"The effect of lopinavir\/ritonavir on the renal clearance of tenofovir in HIV-infected patients","volume":"83","author":"Kiser","year":"2008","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821630271X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821630271X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T18:40:45Z","timestamp":1565376045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821630271X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"alternative-id":["S875632821630271X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.09.017","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}